Clinical Trials
4 trialsNCT04283994 2025-06-24
PICSI-H
University of Washington
Phase NA Completed
NCT04281784 2025-04-04
PICSI-H
University of Washington
Phase NA Completed
NCT03516994 2024-05-16
EQUALACP
Duke University
Phase NA Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed